SBOT - Stellar Biotechnologies misses by $0.05 beats on revenue May, 08 2019 07:51 AM Stellar Biotechnologies Inc. Stellar Biotechnologies (NASDAQ:SBOT): Q2 GAAP EPS of -$0.31 misses by $0.05.More news on: Stellar Biotechnologies, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...